We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Report Shows Micro-Machined Ultrasound Transducers Market Growing

By HospiMedica International staff writers
Posted on 31 Jul 2018
Micro-machined ultrasonic transducers (MUTs), in the form of PMUTs (Piezoelectric micro-machined ultrasonic transducers) and CMUTs (capacitive micro-machined ultrasonic transducers), are finally coming to market. More...
New applications, along with improved manufacturing capabilities and advanced technological readiness, are driving the impressive growth of MUTs.

These are the latest findings of Yole Développement (YoleVilleurbanne, Lyon, France), a market research and consulting company.

Ten years after Hitachi introduced the first ultrasound technology probe, MUT technologies have created a high level of excitement. R&D teams have been working intensively to develop new ultrasonic transducers and overcome the challenges linked to MUTs. The overall ultrasound modules market is estimated to have recorded sales of USD 2.1 billion in 2017 and grow at a significant CAGR of 18% between 2017 and 2023 to reach USD 5.7 billion by 2023. The mass-market for MUTs is about to happen mainly due to some favorable factors.

First, applications are pushing for these technologies. CMUT, which was developed 30 years ago, is traditionally used in medical applications and, has only recently found its killer application – handheld ultrasound. The medical ultrasound market will witness significant changes with the arrival of new products such as the USD 2,000 Butterfly IQ ultrasound probe. This handheld, low-cost device will reshape medical ultrasound usage, with new customers such as primary care, emergency physicians, and nurses using imaging as an everyday tool. Ultrasound is expected to become the new stethoscope. Medical ultrasonic imaging will democratize into general practitioners as well as homes due to cheaper and smaller probes.

Second, the technology is ready. Miniaturization, low cost, and integration are the key drivers for ultrasonic transducers, giving rise to the popularity of new technologies coming from the semiconductor industry. Thirdly, several industry players have consistently invested in these technologies, thus readying the supply chain. Lastly, assembly is an important part of manufacturing, especially if the mass-market is targeted, and companies have readied the supply chain. This alignment of these favorable factors has set the stage for the arrival of MUTs in several applications and markets.

Related Links:
Yole Développement


Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Rapid Sepsis Test
SeptiCyte RAPID
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.